| Literature DB >> 29681406 |
Bruna Stefânia Ferreira Mello1, Adriano José Maia Chaves Filho1, Charllyany Sabino Custódio1, Rafaela Carneiro Cordeiro1, Fabio Miyajima1, Francisca Cléa Florenço de Sousa1, Silvânia Maria Mendes Vasconcelos1, David Freitas de Lucena1, Danielle Macedo2.
Abstract
Peripheral inflammation induced by lipopolysaccharide (LPS) causes a behavioral syndrome with translational relevance for depression. This mental disorder is twice more frequent among women. Despite this, the majority of experimental studies investigating the neurobiological effects of inflammatory models of depression have been performed in males. Here, we sought to determine sex influences in behavioral and oxidative changes in brain regions implicated in the pathophysiology of mood disorders (hypothalamus, hippocampus and prefrontal cortex - PFC) in adult mice 24 h post LPS challenge. Myeloperoxidase (MPO) activity and interleukin (IL)-1β levels were measured as parameters of active inflammation, while reduced glutathione (GSH) and lipid peroxidation as parameters of oxidative imbalance. We observed that male mice presented behavioral despair, while females anxiety-like alterations. Both sexes were vulnerable to LPS-induced anhedonia. Both sexes presented increased MPO activity in the PFC, while male only in the hippocampus. IL-1β increased in the PFC and hypothalamus of animals of both sexes, while in the hippocampus a relative increase of this cytokine in males compared to females was detected. GSH levels were decreased in all brain areas investigated in animals of both sexes, while increased lipid peroxidation was observed in the hypothalamus of females and in the hippocampus of males after LPS exposure. Therefore, the present study gives additional evidence of sex influence in LPS-induced behavioral alterations and, for the first time, in the oxidative changes in brain areas relevant for mood regulation.Entities:
Keywords: Depression; Inflammation; Lipid peroxidation; Lipopolysaccharide; Oxidative stress; Sex
Mesh:
Substances:
Year: 2018 PMID: 29681406 DOI: 10.1016/j.jneuroim.2018.04.009
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478